Sarah Sheehan is a Research Associate at the Duke-Margolis Center for Health Policy working on biomedical innovation, medical product development, and regulatory science initiatives. Sarah’s work at the Center focuses primarily on the ethics of biomedical research and key considerations underpinning regulatory decision-making.
Before joining Duke-Margolis, Sarah was a Health Policy Analyst at the United States Government Accountability Office (GAO) and a Researcher at the Centers for Disease Control and Prevention (CDC). At GAO and CDC, Sarah’s research covered policies related to antimicrobial innovation and healthcare-associated infections.
Health policy analysis, program evaluation, project management, medical product policy, regulatory science, antimicrobials, healthcare-associated infections, biomedical innovation